On the one hand, MAGI1 silencing in the MCF7 breast cancer cell line decreases ESR1 mRNA and ERα protein levels, activates PI3K/Wnt signaling, promotes cell proliferation, and reduces apoptosis and epithelial differentiation. This evidence concerns the gene ESR1 and breast carcinoma.